Some One Health based control strategies for the Middle East respiratory syndrome coronavirus

One Health

Volumn 8, Issue , 2019, Pages

  Hemida, Maged Gomaa ^a,b   Alnaeem, Abdelmohsen ^a  

^a KING FAISAL UNIVERSITY   (Saudi Arabia)

^b Kafrelsheikh University   (Egypt)

Author keywords

Dromedary camel; Human; MERS CoV; One Health; Shedding; Transmission

Indexed keywords

MERS COV S1 VACCINE; UNCLASSIFIED DRUG; VIRUS VACCINE;

BREEDING; CAMEL; COMPETITION; DAIRY PRODUCT; DIETARY INTAKE; DISEASE SURVEILLANCE; GRAZING; HUMAN; INFECTION CONTROL; INFECTION RISK; MARKET; MEAT; MIDDLE EAST RESPIRATORY SYNDROME; MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS; NONHUMAN; ONE HEALTH; REVIEW; RISK REDUCTION; SAUDI ARABIA; SLAUGHTERHOUSE; TRAFFIC AND TRANSPORT; VACCINATION; VIRUS SHEDDING; VIRUS TRANSMISSION;

EID: 85070950196     PISSN: None     EISSN: 23527714     Source Type: Journal    
DOI: 10.1016/j.onehlt.2019.100102     Document Type: Review

References (51)

1. Zaki, A.M., van Boheemen, S., Bestebroer, T.M., Osterhaus, A.D., Fouchier, R.A., Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N. Engl. J. Med. 367:19 (2012), 1814–1820.
2. WHO, Middle East Respiratory Syndrome Coronavirus (MERS-CoV). 2019, World Health Organization Available: http://www.who.int/emergencies/mers-cov/en/2019.
3. Hemida, M.G., Chu, D.K., Poon, L.L., Perera, R.A., Alhammadi, M.A., Ng, H.Y., et al. MERS coronavirus in dromedary camel herd, Saudi Arabia. Emerg. Infect. Dis. 20:7 (2014), 1231–1234.
4. Azhar, E.I., El-Kafrawy, S.A., Farraj, S.A., Hassan, A.M., Al-Saeed, M.S., Hashem, A.M., et al. Evidence for camel-to-human transmission of MERS coronavirus. N. Engl. J. Med. 370:26 (2014), 2499–2505.
5. Peiris, J.S., Guan, Y., Yuen, K.Y., Severe acute respiratory syndrome. Nat. Med. 10:12 Suppl (2004), S88–S97.
6. Wang, M., Yan, M., Xu, H., Liang, W., Kan, B., Zheng, B., et al. SARS-CoV infection in a restaurant from palm civet. Emerg. Infect. Dis. 11:12 (2005), 1860–1865.
7. Cheng, V.C., Chan, J.F., To KK, Yuen, K.Y., Clinical management and infection control of SARS: lessons learned. Antivir. Res. 100:2 (2013), 407–419.
8. Mendez, D., Buttner, P., Speare, R., Hendra virus in Queensland, Australia, during the winter of 2011: veterinarians on the path to better management strategies. Prev Vet Med. 117:1 (2014), 40–51.
9. Middleton, D., Pallister, J., Klein, R., Feng, Y.R., Haining, J., Arkinstall, R., et al. Hendra virus vaccine, a one health approach to protecting horse, human, and environmental health. Emerg. Infect. Dis. 20:3 (2014), 372–379.
10. Wiethoelter, A.K., Schembri, N., Dhand, N.K., Sawford, K., Taylor, M.R., Moloney, B., et al. Australian horse owners and their biosecurity practices in the context of Hendra virus. Prev Vet Med. 148 (2017), 28–36.
11. Kung, N.Y., Field, H.E., McLaughlin, A., Edson, D., Taylor, M., Flying-foxes in the Australian urban environment-community attitudes and opinions. One Health. 1 (2015), 24–30.
12. Khanvilkar, A.V., Samant, S.R., Ambore, B.N., Reproduction in Camel. Veterinary World. 2:2 (2009), 72–73.
13. Ali, M.A., Shehata, M.M., Gomaa, M.R., Kandeil, A., El-Shesheny, R., Kayed, A.S., et al. Systematic, active surveillance for Middle East respiratory syndrome coronavirus in camels in Egypt. Emerg Microbes Infect., 6(1), 2017, e1.
14. Kamau, E., Ongus, J., Gitau, G., Galgalo, T., Lowther, S.A., Bitek, A., et al. Knowledge and practices regarding Middle East Respiratory Syndrome Coronavirus among camel handlers in a Slaughterhouse, Kenya, 2015. Zoonoses Public Health 66:1 (2019), 169–173.
15. Muller, M.A., Meyer, B., Corman, V.M., Al-Masri, M., Turkestani, A., Ritz, D., et al. Presence of Middle East respiratory syndrome coronavirus antibodies in Saudi Arabia: a nationwide, cross-sectional, serological study. Lancet Infect. Dis. 15:5 (2015), 559–564.
16. Zohaib, A., Saqib, M., Athar, M.A., Chen, J., Sial, A.U., Khan, S., et al. Countrywide survey for MERS-coronavirus antibodies in dromedaries and humans in Pakistan. Virol. Sin. 33:5 (2018), 410–417.
17. Woo, P.C., Lau, S.K., Fan, R.Y., Lau, C.C., Wong, E.Y., Joseph, S., et al. Isolation and characterization of dromedary camel coronavirus UAE-HKU23 from dromedaries of the Middle East: minimal serological cross-reactivity between MERS coronavirus and dromedary camel coronavirus UAE-HKU23. Int. J. Mol. Sci., 17(5), 2016.
18. Yusof, M.F., Eltahir, Y.M., Serhan, W.S., Hashem, F.M., Elsayed, E.A., Marzoug, B.A., et al. Prevalence of Middle East respiratory syndrome coronavirus (MERS-CoV) in dromedary camels in Abu Dhabi Emirate, United Arab Emirates. Virus Genes 50:3 (2015), 509–513.
19. Yusof, M.F., Queen, K., Eltahir, Y.M., Paden, C.R., Al Hammadi, Z., Tao, Y., et al. Diversity of Middle East respiratory syndrome coronaviruses in 109 dromedary camels based on full-genome sequencing, Abu Dhabi, United Arab Emirates. Emerg Microbes Infect., 6(11), 2017, e101.
20. Hemida, M.G., Al-Naeem, A., Perera, R.A., Chin, A.W., Poon, L.L., Peiris, M., Lack of middle East respiratory syndrome coronavirus transmission from infected camels. Emerg. Infect. Dis. 21:4 (2015), 699–701.
21. Al Kahlout, R.A., Nasrallah, G.K., Farag, E.A., Wang, L., Lattwein, E., Muller, M.A., et al. Comparative serological study for the prevalence of anti-MERS coronavirus antibodies in high- and low-risk groups in Qatar. J Immunol Res, 2019, 2019, 1386740.
22. Farag, E.A., Reusken, C.B., Haagmans, B.L., Mohran, K.A., Stalin Raj, V., Pas, S.D., et al. High proportion of MERS-CoV shedding dromedaries at slaughterhouse with a potential epidemiological link to human cases, Qatar 2014. Infect Ecol Epidemiol., 5, 2015, 28305.
23. Reusken, C.B., Farag, E.A., Haagmans, B.L., Mohran, K.A., GJt, Godeke, Raj, S., et al. Occupational exposure to dromedaries and risk for MERS-CoV infection, Qatar, 2013-2014. Emerg. Infect. Dis. 21:8 (2015), 1422–1425.
24. Sikkema, R.S., Farag, E., Himatt, S., Ibrahim, A.K., Al-Romaihi, H., Al-Marri, S.A., et al. Risk factors for primary middle east respiratory syndrome coronavirus infection in Camel workers in Qatar during 2013-2014: a case-control study. J. Infect. Dis. 215:11 (2017), 1702–1705.
25. Alshukairi, A.N., Zheng, J., Zhao, J., Nehdi, A., Baharoon, S.A., Layqah, L., et al. High prevalence of MERS-CoV infection in camel workers in Saudi Arabia. MBio., 9(5), 2018.
26. Chu, D.K., Oladipo, J.O., Perera, R.A., Kuranga, S.A., Chan, S.M., Poon, L.L., et al. Middle East respiratory syndrome coronavirus (MERS-CoV) in dromedary camels in Nigeria, 2015. Euro Surveill., 20(49), 2015.
27. Chu, D.K., Poon, L.L., Gomaa, M.M., Shehata, M.M., Perera, R.A., Abu Zeid, D., et al. MERS coronaviruses in dromedary camels, Egypt. Emerg. Infect. Dis. 20:6 (2014), 1049–1053.
28. Chu, D.K.W., Chan, S.M.S., Perera, R., Miguel, E., Roger, F., Chevalier, V., et al. A46 MERS-CoV in Arabian camels in Africa and Central Asia. Virus Evol., 3, 2017 Suppl 1.
29. Kiambi, S., Corman, V.M., Sitawa, R., Githinji, J., Ngoci, J., Ozomata, A.S., et al. Detection of distinct MERS-Coronavirus strains in dromedary camels from Kenya, 2017. Emerg Microbes Infect., 7(1), 2018, 195.
30. Miguel, E., Chevalier, V., Ayelet, G., Ben Bencheikh, M.N., Boussini, H., Chu, D.K., et al. Risk factors for MERS coronavirus infection in dromedary camels in Burkina Faso, Ethiopia, and Morocco, 2015. Euro Surveill., 22(13), 2017.
31. van Doremalen, N., Hijazeen, Z.S., Holloway, P., Al Omari, B., McDowell, C., Adney, D., et al. High prevalence of Middle East respiratory coronavirus in young dromedary camels in Jordan. Vector Borne Zoonotic Dis. 17:2 (2017), 155–159.
32. Chu, D.K.W., Hui, K.P.Y., Perera, R., Miguel, E., Niemeyer, D., Zhao, J., et al. MERS coronaviruses from camels in Africa exhibit region-dependent genetic diversity. Proc. Natl. Acad. Sci. U. S. A. 115:12 (2018), 3144–3149.
33. van Doremalen, N., Bushmaker, T., Karesh, W.B., Munster, V.J., Stability of Middle East respiratory syndrome coronavirus in milk. Emerg. Infect. Dis. 20:7 (2014), 1263–1264.
34. Reusken, C.B., Farag, E.A., Jonges, M., Godeke, G.J., El-Sayed, A.M., Pas, S.D., et al. Middle East respiratory syndrome coronavirus (MERS-CoV) RNA and neutralising antibodies in milk collected according to local customs from dromedary camels, Qatar, April 2014. Euro Surveill., 19, 2014, 23.
35. Funk, A.L., Goutard, F.L., Miguel, E., Bourgarel, M., Chevalier, V., Faye, B., et al. MERS-CoV at the animal-human interface: inputs on exposure pathways from an expert-opinion elicitation. Front Vet Sci., 3, 2016, 88.
36. Falzarano, D., Kamissoko, B., de Wit, E., Maiga, O., Cronin, J., Samake, K., et al. Dromedary camels in northern Mali have high seropositivity to MERS-CoV. One Health. 3 (2017), 41–43.
37. Harcourt, J.L., Rudoler, N., Tamin, A., Leshem, E., Rasis, M., Giladi, M., et al. The prevalence of Middle East respiratory syndrome coronavirus (MERS-CoV) antibodies in dromedary camels in Israel. Zoonoses Public Health 65:6 (2018 Sep), 749–754, 10.1111/zph.12482 Epub 2018 May 31.
38. WHO, Clinical management of severe acute respiratory infections when novel coronavirus is suspected: What to do and what not to do. Available online http://wwwwhoint/entity/csr/disease/coronavirus_infections/InterimGuidance_ClinicalManagement_NovelCoronavirus_11Feb13updf, 2013.
39. WHO, Infection prevention and control during health care for probable or confirmed cases of novel coronavirus (nCoV) infection Interim guidance. Available online http://wwwwhoint/entity/csr/disease/coronavirus_infections/IPCnCoVguidance_06May13pdf, 2013.
40. Khalafalla, A.I., Lu, X., Al-Mubarak, A.I., Dalab, A.H., Al-Busadah, K.A., Erdman, D.D., MERS-CoV in upper respiratory tract and lungs of dromedary camels, Saudi Arabia, 2013-2014. Emerg. Infect. Dis. 21:7 (2015), 1153–1158.
41. WHO, Available online http://www.who.int/entity/csr/disease/coronavirus_infections/LaboratoryTestingNovelCoronavirus_21Dec12.pdf, 2012.
42. Hemida, M.G., Alnaeem, A., Chu, D.K., Perera, R.A., Chan, S.M., Almathen, F., et al. Longitudinal study of Middle East Respiratory Syndrome coronavirus infection in dromedary camel herds in Saudi Arabia, 2014-2015. Emerg Microbes Infect., 6(6), 2017, e56.
43. Hemida, M.G., Perera, R.A., Al Jassim, R.A., Kayali, G., Siu, L.Y., Wang, P., et al. Seroepidemiology of Middle East respiratory syndrome (MERS) coronavirus in Saudi Arabia (1993) and Australia (2014) and characterisation of assay specificity. Euro Surveill., 19(23), 2014.
44. Hemida, M.G., Perera, R.A., Wang, P., Alhammadi, M.A., Siu, L.Y., Li, M., et al. Middle East Respiratory Syndrome (MERS) coronavirus seroprevalence in domestic livestock in Saudi Arabia, 2010 to 2013. Euro Surveill., 18(50), 2013, 20659.
45. Reusken, C.B., Haagmans, B.L., Muller, M.A., Gutierrez, C., Godeke, G.J., Meyer, B., et al. Middle East respiratory syndrome coronavirus neutralising serum antibodies in dromedary camels: a comparative serological study. Lancet Infect. Dis. 13:10 (2013), 859–866.
46. Adney, D.R., Wang, L., van Doremalen, N., Shi, W., Zhang, Y., Kong, W.P., et al. Efficacy of an adjuvanted Middle East Respiratory Syndrome coronavirus spike protein vaccine in dromedary camels and alpacas. Viruses., 11(3), 2019.
47. Alharbi, N.K., Padron-Regalado, E., Thompson, C.P., Kupke, A., Wells, D., Sloan, M.A., et al. ChAdOx1 and MVA based vaccine candidates against MERS-CoV elicit neutralising antibodies and cellular immune responses in mice. Vaccine. 35:30 (2017), 3780–3788.
48. Munster, V.J., Wells, D., Lambe, T., Wright, D., Fischer, R.J., Bushmaker, T., et al. Protective efficacy of a novel simian adenovirus vaccine against lethal MERS-CoV challenge in a transgenic human DPP4 mouse model. NPJ Vaccines., 2, 2017, 28.
49. Song, F., Fux, R., Provacia, L.B., Volz, A., Eickmann, M., Becker, S., et al. Middle East respiratory syndrome coronavirus spike protein delivered by modified vaccinia virus Ankara efficiently induces virus-neutralizing antibodies. J. Virol. 87:21 (2013), 11950–11954.
50. Volz, A., Kupke, A., Song, F., Jany, S., Fux, R., Shams-Eldin, H., et al. Protective efficacy of recombinant modified vaccinia virus ankara delivering Middle East respiratory syndrome coronavirus spike glycoprotein. J. Virol. 89:16 (2015), 8651–8656.
51. WHO, MERS-CoV global summary and assessment of risk. WHO/MERS/RA/August18 Geneva, Switzerland: World Health Organization; 2018 Licence: CC BY-NC-SA 30 IGO, 2018.